Primary Sjögren syndrome-related peripheral neuropathy: A systematic review and meta-analysis.
neurological manifestations
peripheral neuropathy
prevalence
primary Sjögren syndrome (pSS)
small fiber neuropathy
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
24
08
2022
received:
24
01
2022
accepted:
31
08
2022
pubmed:
11
9
2022
medline:
17
12
2022
entrez:
10
9
2022
Statut:
ppublish
Résumé
Primary Sjögren syndrome (pSS) is a chronic, systemic, autoimmune disorder characterized by lymphocytic infiltrates of the exocrine organs, leading to sicca symptoms and parotid enlargement. pSS has been linked to various neurological manifestations, including peripheral neuropathy (PN). We aimed to provide a comprehensive analysis of the currently available evidence regarding pSS-related PN. A literature search in the PubMed database was performed, and 49 papers were eligible to be included in this systematic review and meta-analysis. The pooled prevalence of PN in pSS is estimated to be 15.0% (95% confidence interval = 10.7%-20.7%). The mean age of pSS patients at PN diagnosis is 59 years. Among the patients with pSS and PN, 83% are females. Neuropathic symptoms usually precede or lead to the pSS diagnosis at a 2:1 ratio in patients with pSS-related PN. The commonest type of pSS-related PN is distal axonal polyneuropathy (80% of patients with pSS-related PN), followed by sensory ganglionopathy. Peripheral and cranial mononeuropathies-particularly trigeminal-are also frequent. Risk factors for developing PN include increasing age and presence of vasculitis. Immune-mediated pathogenetic mechanisms are discussed. Glucocorticoids are the most commonly used treatment option for managing pSS-related PN, when associated with vasculitis, followed by the use of intravenous immunoglobulin. PN is very common in pSS patients. Evidence on long-term prognosis of PN in pSS is limited, and further research is needed. Research into the use of immunosuppressive medication in nonvasculitic neuropathies in the context of pSS merits further consideration.
Sections du résumé
BACKGROUND AND PURPOSE
Primary Sjögren syndrome (pSS) is a chronic, systemic, autoimmune disorder characterized by lymphocytic infiltrates of the exocrine organs, leading to sicca symptoms and parotid enlargement. pSS has been linked to various neurological manifestations, including peripheral neuropathy (PN). We aimed to provide a comprehensive analysis of the currently available evidence regarding pSS-related PN.
METHODS
A literature search in the PubMed database was performed, and 49 papers were eligible to be included in this systematic review and meta-analysis.
RESULTS
The pooled prevalence of PN in pSS is estimated to be 15.0% (95% confidence interval = 10.7%-20.7%). The mean age of pSS patients at PN diagnosis is 59 years. Among the patients with pSS and PN, 83% are females. Neuropathic symptoms usually precede or lead to the pSS diagnosis at a 2:1 ratio in patients with pSS-related PN. The commonest type of pSS-related PN is distal axonal polyneuropathy (80% of patients with pSS-related PN), followed by sensory ganglionopathy. Peripheral and cranial mononeuropathies-particularly trigeminal-are also frequent. Risk factors for developing PN include increasing age and presence of vasculitis. Immune-mediated pathogenetic mechanisms are discussed. Glucocorticoids are the most commonly used treatment option for managing pSS-related PN, when associated with vasculitis, followed by the use of intravenous immunoglobulin.
CONCLUSIONS
PN is very common in pSS patients. Evidence on long-term prognosis of PN in pSS is limited, and further research is needed. Research into the use of immunosuppressive medication in nonvasculitic neuropathies in the context of pSS merits further consideration.
Identifiants
pubmed: 36086910
doi: 10.1111/ene.15555
pmc: PMC10087501
doi:
Substances chimiques
Immunoglobulins, Intravenous
0
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
255-265Informations de copyright
© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Références
Clin Exp Rheumatol. 2014 May-Jun;32(3):349-53
pubmed: 24529195
Clin Exp Rheumatol. 2013 Jan-Feb;31(1):103-10
pubmed: 23020902
Acta Neurol Belg. 2022 Apr;122(2):457-463
pubmed: 34611842
Arthritis Care Res (Hoboken). 2019 Jul;71(7):936-948
pubmed: 30221483
Acta Reumatol Port. 2013 Jan-Mar;38(1):29-36
pubmed: 24131909
Brain Behav. 2020 Aug;10(8):e01665
pubmed: 32583978
Br J Rheumatol. 1990 Feb;29(1):21-3
pubmed: 2155037
Annu Rev Pathol. 2014;9:273-85
pubmed: 24050623
Eur J Neurol. 2023 Jan;30(1):255-265
pubmed: 36086910
Ann Clin Transl Neurol. 2020 May;7(5):819-828
pubmed: 32415709
Eur Neurol. 2017;77(1-2):91-102
pubmed: 27997917
Pain Pract. 2019 Apr;19(4):426-434
pubmed: 30636091
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Neurol India. 2019 Jan-Feb;67(Supplement):S94-S99
pubmed: 30688241
Clin Exp Rheumatol. 2007 Jul-Aug;25(4):556-62
pubmed: 17888211
Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87
pubmed: 22563590
Brain Behav. 2017 Nov 24;7(12):e00880
pubmed: 29299392
Clin Rheumatol. 2011 Apr;30(4):485-90
pubmed: 20393864
Aust Dent J. 2010 Jun;55 Suppl 1:39-47
pubmed: 20553243
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Eur J Intern Med. 2020 Sep;79:58-62
pubmed: 32471733
Sci Rep. 2020 Jun 30;10(1):10627
pubmed: 32606345
Medicine (Baltimore). 2013 Sep;92(5):e10-e18
pubmed: 23982054
Arthritis Rheum. 2007 Dec 15;57(8):1520-9
pubmed: 18050172
Adv Ther. 2020 Jul;37(7):3278-3291
pubmed: 32451951
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
Medicine (Baltimore). 2004 Sep;83(5):280-291
pubmed: 15342972
Acta Neurol Scand. 1990 Feb;81(2):144-52
pubmed: 2327235
Arthritis Care Res (Hoboken). 2011 Sep;63(9):1339-44
pubmed: 21584943
Mod Rheumatol. 2021 Jul;31(4):849-855
pubmed: 32996808
Nat Rev Rheumatol. 2013 Sep;9(9):544-56
pubmed: 23857130
J Neurol. 2020 Dec;267(12):3499-3507
pubmed: 32613444
Intern Med. 1997 Oct;36(10):690-3
pubmed: 9372328
Brain. 2005 Nov;128(Pt 11):2518-34
pubmed: 16049042
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):798-802
pubmed: 21172862
Rheumatology (Oxford). 2014 May;53(5):839-44
pubmed: 24369420
Ann Neurol. 1990 Mar;27(3):304-15
pubmed: 2327738
Arch Intern Med. 2004 Jun 28;164(12):1275-84
pubmed: 15226160
Presse Med. 2012 Sep;41(9 Pt 2):e485-93
pubmed: 22840992
Semin Arthritis Rheum. 2000 Apr;29(5):296-304
pubmed: 10805354
Acta Neurol Scand. 1994 Jan;89(1):31-5
pubmed: 8178625
Pain Med. 2019 May 1;20(5):979-987
pubmed: 30247738
Autoimmun Rev. 2010 Mar;9(5):A305-10
pubmed: 19903539
Rheumatol Int. 2017 Jul;37(7):1153-1158
pubmed: 28424927
Medicine (Baltimore). 2002 Jul;81(4):270-80
pubmed: 12169882
Medicine (Baltimore). 2011 Mar;90(2):133-138
pubmed: 21358442
J Rheumatol. 2020 Nov 1;47(11):1661-1667
pubmed: 32062606
Clin Rheumatol. 1999;18(4):299-303
pubmed: 10468169
Neurology. 1993 Dec;43(12):2574-81
pubmed: 8255460
Medicine (Baltimore). 2016 May;95(19):e3632
pubmed: 27175675
J Neurol. 2016 Oct;263(10):1903-10
pubmed: 26961897
Acta Neurol Scand. 1990 Aug;82(2):126-31
pubmed: 2256441
Cerebellum Ataxias. 2017 Dec 22;4:20
pubmed: 29299331
Brain. 2009 Jul;132(Pt 7):1723-33
pubmed: 19506068
PLoS One. 2014 Jan 20;9(1):e84605
pubmed: 24465419
Front Immunol. 2019 Jul 11;10:1600
pubmed: 31354737
J Clin Lab Anal. 1994;8(6):378-84
pubmed: 7869176
Eur J Intern Med. 2014 Feb;25(2):177-81
pubmed: 24176941
Reumatologia. 2018;56(2):99-105
pubmed: 29853725
N Engl J Med. 2018 Mar 08;378(10):931-939
pubmed: 29514034
J Cutan Med Surg. 2011 Jan-Feb;15(1):8-14
pubmed: 21291650
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Biomed Res Int. 2014;2014:902492
pubmed: 24822219
Br J Rheumatol. 1988 Aug;27(4):275-80
pubmed: 3261608
Lupus. 2000;9(1):61-4
pubmed: 10713648
J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):983-6
pubmed: 8057125
Ann Rheum Dis. 2001 Sep;60(9):876-81
pubmed: 11502615
Muscle Nerve. 2020 Apr;61(4):515-520
pubmed: 32012291
J Rheumatol. 2003 Jul;30(7):1552-7
pubmed: 12858457
Clin Rheumatol. 2003 Sep;22(3):256-8
pubmed: 14505225
Neurol Res. 2020 Jan;42(1):17-21
pubmed: 31661424